Document is current
Any future updates will be listed below
-
Authors
Miyo, Masaaki
Kato, Takeshi https://orcid.org/0000-0001-5347-550X
Yoshino, Takayuki
Yamanaka, Takeharu
Bando, Hideaki
Satake, Hironaga
Yamazaki, Kentaro
Taniguchi, Hiroya
Oki, Eiji
Kotaka, Masahito
Oba, Koji
Miyata, Yoshinori
Muro, Kei
Komatsu, Yoshito
Baba, Hideo
Tsuji, Akihito
-
Funding
Funding for this research was provided by:
Chugai Pharmaceutical
- License Information
-
More Information
Article History
Received: 8 April 2020
Accepted: 15 July 2020
First Online: 23 July 2020
Ethics approval and consent to participate
: Before initiation, the principal investigator must consult the Certified Review Board* and receive approval from the study site’s manager and must submit a trial plan to the Minister of Health, Labor and Welfare.* An application for this study will be submitted to the following Certified Review Board: Shizuoka Cancer Center Institutional Review Board (Certification No. CRB4180010).
: Not applicable.
: AT receives honoraria from Chugai Pharmaceutical Co., Ltd. as well as grants from Kyowa Kirin Co., Ltd. TY receives grants from Chugai Pharmaceutical Co., Ltd. HS receives honoraria from Chugai Pharmaceutical Co., Ltd. and Yakult Honsha Co., Ltd. HB receives honoraria from Chugai Pharmaceutical Co., Ltd. and Yakult Honsha Co., Ltd. TY receives honoraria and grants from Chugai Pharmaceutical Co., Ltd. YK receives honoraria and grants from Chugai Pharmaceutical Co., Ltd., Yakult Honsha Co., Ltd., and Kyowa Kirin Co., Ltd. HT receives honoraria from Chugai Pharmaceutical Co., Ltd. and Yakult Honsha Co., Ltd. KM receives fee for speakers’ bureau from Chugai Pharmaceutical Co., Ltd. KY receives honoraria from Chugai Pharmaceutical Co., Ltd. and Yakult Honsha Co., Ltd. EO receives lecture fees from Chugai Pharmaceutical Co., Ltd. MK receives honoraria from Chugai Pharmaceutical Co., Ltd. and Yakult Honsha Co., Ltd. KO receives honoraria from Chugai Pharmaceutical Co. HB receives research funding and fees for speakers’ bureau from Chugai Pharmaceutical Co., Ltd. All authors declared that they have no other competing interests.
